Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$391M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$376M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$361M |
| 4 |
Johnson & Johnson
JNJ
|
+$258M |
| 5 |
Procter & Gamble
PG
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
X
US Steel
X
|
+$421M |
| 3 |
NVIDIA
NVDA
|
+$375M |
| 4 |
Deere & Co
DE
|
+$226M |
| 5 |
JPMorgan Chase
JPM
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.92% |
| 2 | Financials | 18.53% |
| 3 | Industrials | 12.39% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Healthcare | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Lineage Cell Therapeutics
LCTX
$257M
| $36.7K | ﹤0.01% |
40,449
| – | – |
|
|
FORA
3252
DELISTED
Forian
FORA
| $36.5K | ﹤0.01% |
18,630
+487
| +3% | +$985 |
|
3253
Adicet Bio
ACET
$72.8M
| $34.9K | ﹤0.01% |
3,579
-5,659
| -61% | -$59.7K |
|
|
VXRT
3254
DELISTED
Vaxart
VXRT
| $34.1K | ﹤0.01% |
75,491
| – | – |
|
|
CARV
3255
DELISTED
Carver Bancorp
CARV
| $30.1K | ﹤0.01% |
17,408
| – | – |
|
|
HOOK
3256
DELISTED
HOOKIPA Pharma
HOOK
| $30.1K | ﹤0.01% |
23,948
-4,483
| -16% | -$5.54K |
|
|
TMQ
3257
Trilogy Metals
TMQ
$522M
| $29.3K | ﹤0.01% |
21,693
| – | – |
|
3258
Century Casinos
CNTY
$32.9M
| $28.9K | ﹤0.01% |
13,685
-122,423
| -90% | -$218K |
|
3259
Educational Development Corp
EDUC
$12.4M
| $28.5K | ﹤0.01% |
21,398
| – | – |
|
3260
Energy Vault
NRGV
$522M
| $27.5K | ﹤0.01% |
38,336
+2
| +0% | +$2 |
|
3261
Acrivon Therapeutics
ACRV
$68.5M
| $26.4K | ﹤0.01% |
22,204
-21,950
| -50% | -$30.1K |
|
3262
Battalion Oil
BATL
$35.9M
| $25.1K | ﹤0.01% |
19,404
-2,365
| -11% | -$3.38K |
|
3263
Aprea Therapeutics
APRE
$7.83M
| $24.6K | ﹤0.01% |
14,465
-2,190
| -13% | -$3.73K |
|
3264
PDS Biotechnology
PDSB
$38.1M
| $24.4K | ﹤0.01% |
18,382
| – | – |
|
3265
Marker Therapeutics
MRKR
$20.3M
| $24.3K | ﹤0.01% |
15,900
| – | – |
|
3266
Great Elm Group
GEG
$68.4M
| $24.1K | ﹤0.01% |
11,419
| – | – |
|
3267
PharmaCyte Biotech
PMCB
$6.44M
| $22.3K | ﹤0.01% |
20,299
| – | – |
|
3268
Cocrystal Pharma
COCP
$12.4M
| $21K | ﹤0.01% |
14,092
-504
| -3% | -$750 |
|
3269
PMV Pharmaceuticals
PMVP
$66.1M
| $17.2K | ﹤0.01% |
16,210
-109,794
| -87% | -$108K |
|
|
IAUX
3270
i-80 Gold Corp
IAUX
$1.17B
| $9.52K | ﹤0.01% |
15,900
+1,000
| +7% | +$590 |
|
3271
Immunic
IMUX
$182M
| $9.17K | ﹤0.01% |
1,315
-1,437
| -52% | -$13.2K |
|
3272
Ring Energy
REI
$322M
| $8.97K | ﹤0.01% |
11,409
| – | – |
|
3273
Aligos Therapeutics
ALGS
$25.2M
| – | – |
-11,216
| Closed | -$92.5K |
|
3274
AnaptysBio
ANAB
$1.6B
| – | – |
-31,571
| Closed | -$587K |
|
3275
Arlo Technologies
ARLO
$1.4B
| – | – |
-28,351
| Closed | -$280K |
|
Similar funds
Dimensional Fund Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Dimensional Fund Advisors held 3,373 positions worth $432B, up 7.4% from $402B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.6%. Dimensional Fund Advisors opened 53 new positions and exited 101, leaving the 3,373-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2025 buy was Ralliant Corp: 965,437 shares worth $46.9M.
- Dimensional Fund Advisors added most to Capital One in Q2 2025, an estimated $391M increase.
- Dimensional Fund Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $375M.
- Dimensional Fund Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $536M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $432B portfolio in Q2 2025.
- Dimensional Fund Advisors opened 53 new positions and closed 101 in Q2 2025.
- Dimensional Fund Advisors's portfolio value rose 7.4% quarter-over-quarter to $432B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.